A detailed history of Abel Hall, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Abel Hall, LLC holds 2,434 shares of ABBV stock, worth $430,696. This represents 0.31% of its overall portfolio holdings.

Number of Shares
2,434
Previous 2,348 3.66%
Holding current value
$430,696
Previous $403 Million 19.35%
% of portfolio
0.31%
Previous 0.28%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$163.84 - $199.33 $14,090 - $17,142
86 Added 3.66%
2,434 $481 Million
Q2 2024

Jul 25, 2024

BUY
$154.79 - $180.76 $23,682 - $27,656
153 Added 6.97%
2,348 $403 Million
Q1 2024

May 08, 2024

SELL
$159.82 - $182.1 $327,151 - $372,758
-2,047 Reduced 48.26%
2,195 $400 Million
Q4 2023

Feb 28, 2024

BUY
$137.6 - $154.97 $583,699 - $657,382
4,242 New
4,242 $657 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $313B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Abel Hall, LLC Portfolio

Follow Abel Hall, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abel Hall, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abel Hall, LLC with notifications on news.